Snowball logo
logo
6016

Shanghai Pharmaceuticals Holding Co Ltd

601607 • SHG
¥16.22+¥0.22  (1.38%)
Estimate
P/E
10.4
EPS
1.56
Beta
0.156
Growth
Revenue, YoY
6.36%
Net income, YoY
6.35%
FCF, YoY
42.17%
Forecast
P/E (FWD)
10.1
EPS (FWD)
1.604
About the company
Ticker
601607
ISIN
CNE000000C82
Country
China
Sector (GICS)
Healthcare
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as invests in equity. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.

Frequently asked questions

What sector does Shanghai Pharmaceuticals Holding Co Ltd (601607) operate in?

Shanghai Pharmaceuticals Holding Co Ltd belongs to the Healthcare sector and operates in the Medical Distribution industry.

What is Shanghai Pharmaceuticals Holding Co Ltd (601607) current stock price?

As of the latest data, Shanghai Pharmaceuticals Holding Co Ltd stock price is CN¥16.22, with a previous close of CN¥16.00. Shanghai Pharmaceuticals Holding Co Ltd gained CN¥0.22 in the last trading session, representing a 1.38% increase.

What is Shanghai Pharmaceuticals Holding Co Ltd (601607) current market capitalization?

Shanghai Pharmaceuticals Holding Co Ltd market cap is approximately 45.24 billion.

What is Shanghai Pharmaceuticals Holding Co Ltd (601607) Earnings Per Share (EPS)?

The trailing EPS is CN¥1.56, and the forward EPS is CN¥1.60.

What is Shanghai Pharmaceuticals Holding Co Ltd (601607) Price-to-Earnings (P/E) ratio?

Shanghai Pharmaceuticals Holding Co Ltd current P/E ratio is 10.4, with a forward P/E of 10.11.

Does Shanghai Pharmaceuticals Holding Co Ltd (601607) pay dividends?

No. Shanghai Pharmaceuticals Holding Co Ltd does not pay a dividend.

How did Shanghai Pharmaceuticals Holding Co Ltd (601607) perform in its most recent earnings report?

In the last report (June 30, 2026), Shanghai Pharmaceuticals Holding Co Ltd posted an EPS surprise of 11.76% and a revenue surprise of 1.48%.

What is Shanghai Pharmaceuticals Holding Co Ltd (601607) beta (volatility) score?

Shanghai Pharmaceuticals Holding Co Ltd has a beta of 0.156, indicating lower volatility than the overall market.